Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxami de, preparation method thereof and use of same in therapeutics

Details for Australian Patent Application No. 2005212867 (hide)

Owner sanofi-aventis

Inventors Galli, Frederic; Leclerc, Odile; Lochead, Alistair

Agent Davies Collison Cave

Pub. Number AU-B-2005212867

PCT Pub. Number WO2005/077955

Priority 0400390 16.01.04 FR

Filing date 7 January 2005

Wipo publication date 25 August 2005

Acceptance publication date 12 May 2011

International Classifications

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/077955 Priority application(s): WO2005/077955

12 May 2011 Application Accepted

  Published as AU-B-2005212867

8 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005212868-Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics

2005212857-Novel guanidinyl-substituted hydroxy6-phenylphenenthridines as effective phosphodiesterase (PDE) 4 inhibitors